Chang Cheng, Swaan Peter W
Department of Pharmaceutical Sciences, University of Maryland, Baltimore, MD 21201, USA.
Eur J Pharm Sci. 2006 Apr;27(5):411-24. doi: 10.1016/j.ejps.2005.09.013. Epub 2005 Nov 4.
Computational modeling has advanced our understanding of drug absorption, tissue distribution, excretion and toxicity profiles by providing both direct and indirect knowledge of drug-transporter interactions that would otherwise be unavailable using experimental methods. Currently, two complementary approaches are available in modeling transporters: substrate-based and transporter-based methods. The transporter-based approach directly predicts the transporter's three-dimensional structure to assist in understanding the drug transport process, whereas substrate-based models infer such information by studying a group of substrates or inhibitors with measured activities. In this review, the available strategies in both transporter-based and substrate-based approaches are explained and illustrated with applications and case studies. With increasing computational power and continuously improving modeling algorithms, computational techniques can assist in further understanding transporter-substrate interactions as well as, the optimization of transporter-directed drug design.
计算建模通过提供药物-转运体相互作用的直接和间接知识,推进了我们对药物吸收、组织分布、排泄和毒性特征的理解,而这些知识用实验方法是无法获得的。目前,在转运体建模中有两种互补的方法:基于底物的方法和基于转运体的方法。基于转运体的方法直接预测转运体的三维结构,以帮助理解药物转运过程,而基于底物的模型则通过研究一组具有测量活性的底物或抑制剂来推断此类信息。在这篇综述中,基于转运体和基于底物的方法中的可用策略都将通过应用和案例研究进行解释和说明。随着计算能力的不断提高和建模算法的持续改进,计算技术可以帮助进一步理解转运体-底物相互作用,以及优化针对转运体的药物设计。